Home Search
lead - search results
If you're not happy with the results, please do another search
Renewable energy: Wave power works
Wave power works, argues Jonas Kamf, CEO of W4P Waves4Power AB in this special renewable energy focus.
New mothers twice as likely to have post-natal depression during pandemic
During the first COVID lockdown, almost half of women with babies aged six months or younger experienced post-natal depression, according to UCL researchers.
Railways in the UK and Japan: Heritage tourism focus
Hideto Fujii, Professor from School of Commerce, Meiji University in Japan, describes revitalising rural & urban areas through heritage tourism in this special focus on railways in the UK and Japan.
Supporting economic growth & regeneration in the UK
Bev Hurley CBE, Chair of the Institute of Economic Development, calls for "a sharp and clear focus" in the Shared Prosperity Fund to reduce inequality.
Social welfare research: Foster care support
Professor Kayoko ITO works on a range of social welfare and social work studies, including a foster care support model, as we discover here.
Let’s learn how to use plastic anew!
Research Professor Ali Harlin urges us to reconsider our plastic use and illustrates how the VTT Technical Research Centre of Finland is aiming to halve the environmental impact of plastics.
Modelling Armageddon: The effects of nuclear weapons on climate
Owen B. Toon, Alan Robock & Richard P. Turco turn our thoughts towards modelling Armageddon in terms of the effects of nuclear weapons on climate.
How can the public sector make critical and efficient data-driven decisions?
Christian Marsden, Head of Financial Services and Government at Dun & Bradstreet, discusses how the public sector can make critical and efficient data-driven decisions.
Mental Health Awareness week: Working effectively and sustainably
Ahead of Mental Health Awareness week, industry experts discuss what employers can do to support employee wellbeing through remote working and beyond.
Researchers given £5m to understand COVID-19 severity in India and the UK
Four research partnerships have been awarded £5 million to provide a deeper understanding of COVID-19 severity in India and the UK.
What happens now that the US supports the TRIPS waiver?
Rachel Thrasher, Research Fellow at the Global Development Policy Center in Boston, explains how the new US stance could change the TRIPS waiver debate.
Regularly eating sardines can prevent type 2 diabetes
A new study has discovered that the regular consumption of sardines helps to prevent the onset of type 2 diabetes.
One in five UK adults experienced depression during lockdown
According to new ONS data, one in five adults experienced some form of depression during lockdown - more than double the pre-pandemic rate.
Only 41% of people are willing to sign up for COVID-19 vaccine trials
New research from the University of Birmingham shows that only 41% of people would be willing to sign up for COVID-19 vaccine trials.
Countries denied access to vaccines they helped develop
A new study has revealed that new medicines and vaccines approved for use in the United States are often unavailable in countries that helped to develop them.
Sea level rise could be halved this century under Paris Agreement target
A new study has found that sea level rise from the melting of ice could be halved this century if we meet the Paris Agreement target of limiting global warming to 1.5°C.
53% of cancer patients are experiencing loneliness during the pandemic
According to a new study, more than half (53%) of adult cancer patients have been experiencing loneliness during the COVID-19 pandemic.
Indro Mukerjee appointed new CEO of Innovate UK
Indro Mukerjee has been appointed the new CEO of Innovate UK, the UK’s innovation agency.
Is telecommuting good for the environment?
Here Pascal Paillé, professor of sustainable Human Resource Management, NEOMA Business School, discusses telework and ecology, and explores whether telecommuting is actually good for the environment.
Doctors stop vaccine-blood clot with heparin alternative
A patient with vaccine-inducted thrombotic thrombocytopenia was successfully treated with a heparin alternative, after receiving the Johnson & Johnson vaccine.
